← Issue №18/ week of Nov 1, 2026/Hepatology

Missed Diagnosis in Alcohol-Related Hepatocellular Carcinoma: A Call for Alcohol Consumption and Liver Disease Early Detection.

From GI Signals issue №18: what this paper found, what it changes, and where it sits against the current standard of care, reviewed by Simon Mathews, MD.

Hepatology review · Nov 1, 2026 · Liver International · IF 6.7

Missed Diagnosis in Alcohol-Related Hepatocellular Carcinoma: A Call for Alcohol Consumption and Liver Disease Early Detection.

Guideline / reviewalcohol-associated liver diseasehepatocellular carcinomaepidemiologyhealth services
Clinical takeawayThe review calls for closer collaboration between hepatology and addiction medicine, and population-level alcohol reduction, to raise surveillance uptake in alcohol-related liver disease.
What it foundA substantial proportion of alcohol-related HCC is diagnosed at an advanced stage, often because underlying liver disease was not identified and surveillance was not implemented; alcohol use disorder, comorbidities and socioeconomic vulnerability complicate care.
ContextThis literature reports that alcohol-related hepatocellular carcinoma is frequently diagnosed at advanced stages due to missed early detection of underlying liver disease.
No standard claimed for this paper

Every paper is compared to the standard governing its question. This one is not: either no standard in the corpus matches it, or the comparison did not hold up on review and was withdrawn rather than published unverified. Both are logged.

Mignot V … Costentin C · Liver International : Official Journal of the International Association for the Study of the Liver · IF 6.7 · PubMed ↗Permalink
← Read the whole of issue №18 Every paper GI Signals surfaces gets a page like this one. All issues